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Gene Profiling of Keloid Fibroblasts Shows Altered
Expression in Multiple Fibrosis-Associated Pathways
Joan C. Smith1, Braden E. Boone2, Susan R. Opalenik3, Scott M. Williams4 and Shirley B. Russell4,5
Keloids are benign tumors of the dermis that form during a protracted wound healing process. Susceptibility to
keloid formation occurs predominantly in people of African and Asian descent. The key alteration(s)
responsible for keloid formation has not been identified and there is no satisfactory treatment for this disorder.
The altered regulatory mechanism is limited to dermal wound healing, although several diseases characterized
by an exaggerated response to injury are prevalent in individuals of African ancestry. We have observed a
complex pattern of phenotypic differences in keloid fibroblasts grown in standard culture medium or induced
by hydrocortisone (HC). In this study Affymetrix-based microarray was performed on RNA obtained from
fibroblasts cultured from normal scars and keloids grown in the absence and presence of HC. We observed
differential regulation of approximately 500 genes of the 38,000 represented on the Affymetrix chip. Of
particular interest was increased expression of several IGF-binding and IGF-binding-related proteins and
decreased expression of a subset of Wnt pathway inhibitors and multiple IL-1-inducible genes. Increased
expression of connective tissue growth factor and insulin-like growth factor binding protein-3 was observed in
keloid fibroblasts only in the presence of HC. These findings support a role for multiple fibrosis-related
pathways in the pathogenesis of keloids.
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INTRODUCTION
Keloids are benign collagenous dermal tumors that form
during a protracted wound healing process (Niessen et al.,
1999; Marneros et al., 2004). The predisposition to form
keloids is found predominantly in people of African and Asian
descent. Although this disfiguring disorder of wound healing
significantly impairs the quality of life (Bock et al., 2006), it is
understudied relative to other chronic skin disorders. The key
alteration(s) responsible for keloid formation has not been
identified, and there is no satisfactory treatment. Keloid
formation is one of a group of fibroproliferative diseases
characterized by an exaggerated response to injury that occur
at higher frequency or with more severe manifestations in
people of African ancestry. These diseases include hypertension
(Dustan, 1995), nephrosclerosis (August and Suthanthiran,
2003), scleroderma (Mayes et al., 2003), sarcoidosis (Rybicki
et al., 1998), allergic disease (Nickel et al., 1999), and uterine
fibroma (Flake et al., 2003). We (Russell et al., 1989) and others
(Dustan, 1995; August and Suthanthiran, 2003; Catherino et al.,
2004) have suggested that a common etiopathology may
operate in these diseases, and that common genetic factors
may account for their unusual racial distribution.
A strong genetic component for keloid formation is
supported by its different frequency of occurrence in different
racial and ethnic populations. Keloids have been estimated to
occur inB1/30 African Americans andB1/625 of the overall
US population (Barrett, 1973). Although most cases occur
sporadically, familial occurrence is observed. In a study of 14
pedigrees with familial keloids, inheritance patterns were
consistent with autosomal dominant inheritance with incom-
plete penetrance and variable expression (Marneros et al.,
2001). Locus heterogeneity is likely; in one family linkage to
chromosome region 14q22–q23 was detected (Davis et al.,
2000), whereas in two other families linkage to regions 2q23
and 7p11 was shown (Marneros et al., 2004). However, no
major genes or susceptibility loci have been identified.
Although some cases may be due to somatic mutation
(Saed et al., 1998), evidence for a multicellular origin of
keloids (Trupin et al., 1977; Moulton-Levy et al., 1984;
Chevray and Manson, 2004) argues against somatic mutation
as the primary event, and suggests that an environmental
factor present during wound healing triggers abnormal gene
expression in genetically susceptible individuals.
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By comparing fibroblast cultures from normal scars and
keloids, we have demonstrated differences in growth and
matrix synthesis that may play a role in the prolonged activity
of keloid fibroblasts in vivo (Russell et al., 1988). These
include reduced serum dependence of low-density keloid
cultures, resistance of keloid fibroblasts to glucocorticoid
downregulation of collagen and elastin gene expression,
altered growth response to glucocorticoids (Russell et al.,
1978, 1989, 1995), and resistance to growth inhibition by
transforming growth factor-b (TGF-b; Russell et al., 1988) and
phorbol ester tumor promoters (Myles et al., 1992).
The altered response to glucocorticoids is observed only in
fibroblasts from the keloid nodule; fibroblasts cultured from
the superficial dermis of keloids and from other dermal sites
of keloid patients behave like normal skin and scar fibroblasts
(Russell et al., 1978, 1989, 1995). Fibroblasts from the keloid
nodule, therefore, appear to be epigenetically distinct from
other dermal fibroblasts in the affected individual.
Gene profiling studies using microarray technology have
identified previously unsuspected genes and pathways of
potential relevance to the pathogenesis of many diseases,
including fibrotic disorders such as keloids (Naitoh et al.,
2005; Tosa et al., 2005; Satish et al., 2006), scleroderma
(Zhou et al., 2001; Whitfield et al., 2003), and leiomyoma
(Tsibris et al., 2002; Mangioni et al., 2005). Microarray
studies have also identified common patterns of altered gene
expression in autoimmune disorders (Aune et al., 2003) and
have focused attention on candidate genes in chromosomal
regions linked to specific diseases (Li et al., 2003; Aune et al.,
2004). To identify pathways critical to keloid pathogenesis
and to define the altered program in lesional fibroblasts, we
have carried out genome-wide expression profiling on
normal and keloid fibroblasts grown in the absence and
presence of hydrocortisone (HC).
RESULTS
Normal and keloid fibroblasts differ in expression of a large
number of genes
To define the altered gene expression pattern in keloid
fibroblasts, RNA was isolated from confluent cultures from
five keloids and five normal scars fed daily with standard
culture medium or medium containing 1.5 mM HC. This
concentration is in the physiological range, and it maximizes
a differential effect on maximum cell density of normal and
keloid fibroblasts (Russell et al., 1978) and inhibits collagen
and elastin synthesis in fibroblasts from normal scars but not
in fibroblasts from the keloid lesion (Russell et al., 1978,
1989, 1995). Biotinylated complementary RNA was prepared
and hybridized to an Affymetrix GeneChip containing
sequences from 38,500 human genes. Hybridized comple-
mentary RNA was visualized, and image data were used to
generate gene expression values. The RNA from one normal
culture, strain 58 grown with HC, was lost during processing.
The remaining 19 samples were subjected to microarray
analysis.
Preliminary analysis using a twofold or greater change in
gene expression identified many differences between the two
cell types in control medium, with 175 defined genes
expressed at higher levels in keloid fibroblasts and 559 at
reduced levels. When HC was added, keloid cells showed
higher expression of 221 genes and lower expression of 547
genes. Approximately 600 genes were downregulated and
400 upregulated at least twofold by HC to a similar extent in
both cell types. A small subset of genes was up- or down-
regulated only in one cell type.
Unsupervised hierarchical clustering analysis (Figure 1)
revealed that normal and keloid fibroblasts grown with and
without HC comprise four distinguishable groups.
Statistical analysis of differences in gene expression between
normal and keloid fibroblasts with and without HC
supplementation
In the absence of HC, 511 genes of known function were
expressed at significantly different levels in keloid and normal
cells when analyzed by nonparametric testing using a
correction for multitesting. The criterion of up- or down-
regulation of at least twofold was not imposed here.
Keloid
+HC
Normal
+HC
NormalKeloid
Figure 1. Unsupervised hierarchical clustering analysis of normal and keloid
fibroblasts grown with and without HC. Unsupervised hierarchical clustering
was performed on 19 samples of normal and keloid fibroblasts grown with
and without HC, using a subset of genes (n¼7303) whose expression varied
by at least twofold relative to the average normal strain in at least two of the
19 samples. Gene expression of cell strains grown in medium with and
without (control) 1.5 mM HC supplementation fell into four distinguishable
groups relative to gene expression in the average normal strain grown in
control medium. From right to left are five normal strains in control medium,
four normal strains with HC (one strain lost in processing), five keloid strains
in control medium, five keloid strains with HC. Red indicates increased
expression, blue indicates reduced expression, and yellow indicates no
difference in expression.
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Parametric testing revealed only 177 genes with statistically
significant differences in expression. In the presence of HC,
nonparametric analysis revealed 515 differentially expressed
genes, whereas parametric testing identified only 236 genes.
Differences in number observed by these two methods of
analysis are due to large variation between strains in
magnitude of differences. As microarray data are often noisy
and not normally distributed, nonparametric methods that do
not assume a specific distribution of data are preferable
(Troyanskaya et al., 2002).
Nonparametric analysis revealed a subset of genes, many
implicated previously in wound healing and fibrosis, which
were expressed at higher (Table 1) or lower (Table 2) levels in
keloid fibroblasts grown in standard culture medium. Tables
3 and 4 list subsets of genes that were differentially expressed
in HC-supplemented medium. For genes that have multiple
probes on the Affymetrix chip, the average difference in
expression and number of informative probe sets are shown.
Genes that also exhibited statistically significant differences
in expression using a parametric test with correction for
multitesting are footnoted. All genes whose expression
differed significantly between normal and keloid strains using
nonparametric analysis are listed in Tables S1 (minus HC)
and S2 (plus HC).
Most genes were differentially expressed to a similar
extent in both the absence and presence of HC, although as
presented in Tables 1–4 and as described below, some
differences were seen only without or only with HC.
Expression of multiple homeotic genes is reduced in keloid
fibroblasts
In addition to altered expression of many individual genes,
we observed a significant reduction in expression of multiple
genes in several clusters of homeotic (HOX) genes, important
Table 1. Subset of genes with increased expression in keloid fibroblasts in the absence of HC
Gene name (Gene symbol)
Keloid/normal
(number probe sets) Biological function
Chromosomal
location
Asporin (ASPN) 34.77 (2) Interaction with TGF-b and collagen 9q22.31
Coagulation factor II (thrombin)
receptor (F2R)1
8.17 (1) Blood coagulation response to
wounding
5q13
Coagulation factor II (thrombin-like)
receptor (F2RL2)
19.89 (1) Blood coagulation response to
wounding
5q13
Cyclin D2 (CD2) 11.13 (1) Regulation of cell-cycle promotion 12p13
Disheveled-associated activator of
morphogenesis 1 (DAAM1)
1.77 (2)) Cell organization and biogenesis 14q22–q23
Frizzled homolog of, 4 (FZD4) 7.92 (1) Wnt pathway receptor 11q14.1
Four and a half LIM domains 1
(FHL1)1
3.01 (5) Cell differentiation Xq27
IGF-binding protein 2 (IGFBP2) 40.18 (1) Regulation of cell growth 2q33–34
IGF-binding protein 5 (IGFBP5)1 7.03 (6) Regulation of cell growth 2q33–34
IGF-binding protein 7 (IGFBP7)1 4.49 (3) Regulation of cell growth 4q12
Jagged 1 (JAG1)1 9.89 (3) Notch signaling pathway 20p12
Mesoderm-specific transcript
(MEST)1
36.68 (1) Mesoderm development 7q32
Nerve growth factor beta (NGFB) 2.93 (1) Cell–cell signaling, development 1p13
Netrin 4 (NTN4)1 12.21 (1) Basement membrane/extracellular
matrix
12q23
Nuclear factor 1/B (NF1B)1 3.85 (4) Transcription factor activity 9p24
Nuclear receptor subfamily 2 group
F2 (NR2F2)
2.66 (3) Regulation of transcription 15q26
piggyBac transposable element-
derived 3 (PGBD3)1
3.90 (3) DNA repair 10q11.23
RAB3B1 3.64 (3) Small GTPase-mediated signal
transduction
1p32
Sine oculis 1 (SIX1) 3.03 (1) Regulation of transcription 14q23
Signal transducer and activator of
transcription 1 (STAT1)1
2.22 (2) Regulation of transcription 2q32
HC, hydrocortisone.
1Statistically significant by parametric as well as nonparametric analysis.
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Table 2. Subset of genes with decreased expression in keloid fibroblasts in the absence of HC
Gene name (Gene symbol)
Keloid/normal
(number probe sets) Biological function
Chromosomal
location
Angiopoietin 1 (ANGPT) 0.13 (2) Angiogenesis, signal
transduction, development
8q22–q23
Chemokine (CXC) ligand 1
(CXCL1)1
0.05 (1) Chemotaxis, inflammatory
response, cell proliferation
4q21
Chemokine (CXC) ligand 12
(CXCL12)
0.42 (2) Inflammatory response, immune
response, cell adhesion, cell–cell
signaling
10q11.1
Chemokine (CXC) ligand 14
(CXCL14)
0.12 (1) Inflammatory response, immune
response
Collagen type XVIII alpha 1
(COL18A1)1
0.23 (2) Cell adhesion, cell proliferation,
organ morphogenesis
21q22.3
Cyclin-dependent kinase
inhibitor 1C (CDKN1C)
0.34 (4) Negative regulation of cell
proliferation
11p15.5
Cyclin-dependent kinase
inhibitor 3 (CDKN3)
0.36 (2) Negative regulation of cell
proliferation
14q22
Dermatopontin (DPT) 0.15 (3) Cell adhesion 1q12-q23
Dickkopf homolog 1 (DKK1) 0.45 (1) Negative regulation of Wnt
signaling pathway
10q11.2
Dickkopf homolog 3 (DKK3) 0.31 (3) Negative regulation of Wnt
signaling pathway
11p15.2
Discs large homolog 7
(DLG7)1
0.25 (1) Cell–cell signaling, cell
proliferation
14q22.2
Interleukin-1 receptor, type 1
(ILR1)
0.42 (1) Signal transducer activity 2q12
Interleukin-7 (IL7)1 0.06 (1) Immune response, cell–cell
signaling
8q12-q13
Interleukin-8 (IL8)1 0.03 (1) Angiogenesis, cell motility,
chemotaxis, cell proliferation,
cell adhesion
4q13–q21
Matrix metalloproteinase 3
(MMP3)1
0.03 (1) Collagen catabolism 11q22.3
Membrane metallo-
endopeptidase (MME)
0.08 (2) Proteolysis and peptidolysis 3q25.1–q25.2
Pleiotrophin (heparin-binding
growth factor) (PTN)
0.10 (3) Cell-cycle regulation 7q33–q34
Secreted frizzled related
protein 1 (SFRP1)
0.02 (3) Negative regulation Wnt
signaling pathway
8p12–p11.1
Stathmin-like 2 (STMN2)1 0.01 (2) Intracellular signaling 8q21.11–q21.12
Syndecan (SDC1)1 0.26 (2) Cytoskeletal protein binding 2p24.1
Tenascin C (TNC) 0.52 (1) Cell adhesion 9q33
Thyroid hormone receptor,
beta (THRB)1
0.04 (2) Transcriptional regulation 3p24.1
Tissue factor pathway
inhibitor 2 (TFPI2)1
0.04 (2) Blood coagulation,
endopeptidase inhibitor
7q21.3
Transforming growth factor-b
receptor II (TGFBR2)
0.52 (2) Cell proliferation, extracellular
matrix production
3p22
HC, hydrocortisone.
1Statistically significant by parametric as well as nonparametric analysis.
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regulators of transcription, (Table 5) in the absence and
presence of HC.
Multiple IGF-binding and IGF-binding-related proteins are
overexpressed in keloid fibroblasts
As seen in Tables 1 and 3, expression of several IGF-binding
(IGFBPs) and IGFBP-related proteins was significantly in-
creased. Table S3 compares the expression of additional
genes in this superfamily, as well as STAT-1, a mediator of
IGFBP-3 activity (Spagnoli et al., 2002), in cultures grown
with and without HC, using multiple probe sets on the
Affymetrix chip. For some of these genes the difference in
expression was more than twofold but was not statistically
significant, or as seen for IGFBP-3 differential expression was
statistically significant only when a correction for multitesting
was not used. IGFBP-2, -5, and -7 and STAT-1 were
overexpressed in the absence and presence of HC. However,
IGFBP-3 was only expressed at significantly higher levels
(1.75-fold) in keloid cells grown with HC (Po0.04). As seen
in Table S3 and in Table 3, the IGFBP-related protein,
connective tissue growth factor (CTGF; IGFBP-8), was also
only expressed at significantly higher levels in keloid
fibroblasts when grown with HC (P¼0.0002). The increased
level of IGFBP-3 in keloid cells compared with normal cells
grown in HC was due to a 54% reduction of expression in
normal cells but only a 16% reduction in keloid cells. The
increased expression of CTGF was due to a 46% reduction by
HC in normal cells but a 40% increase in keloid cells. These
findings extend the subset of fibrosis-associated genes that are
glucocorticoid resistant in keloid cells.
Multiple genes in the Wnt signaling pathway are misexpressed
in keloid fibroblasts
Expression of three inhibitors of Wnt signaling, DKK1, DKK3,
and secreted frizzled related protein 1 (SFRP1) was decreased
in keloid fibroblasts (Table 2), whereas expression of the Wnt
stimulatory molecules FZD4 and DAAM1 was increased
(Table 1). Moreover, expression of jagged 1 (JAG1), a ligand
of the Notch signaling pathway and a target of Wnt signaling
(Katoh and Katoh, 2006), was increased approximately
Table 3. Subset of genes with increased expression in keloid fibroblasts in the presence of HC
Gene name (Gene symbol)
Keloid/normal (number
probe sets) Biological function
Chromosomal
location
Asporin (ASPN)1 49.21 (2) Interaction with other extracellular
matrix proteins and TGF-b
9q22.31
Coagulation factor II (thrombin )
receptor (F2R)1
16.19 (1) Blood coagulation response to
wounding
5q13
Coagulation factor II (thrombin-like)
receptor (F2RL2)1
31.98 (1) Blood coagulation response to
wounding
5q13
Connective Tissue Growth Factor
(CTGF)1
2.51 (1) Cell growth, response to wounding 6q23
Elastin (ELN) 4.15 (1) Extracellular matrix component,
organ morphogenesis
7q11.23
Four and a half LIM domains 1
(FHL1)1
2.79 (5) Cell differentiation Xq27
Frizzled homolog of, 4 (FZD4)1 4.51 (1) Wnt pathway receptor 11q14.1
IGF binding protein 5 (IGFBP5) 15.22 (2) Regulation of cell growth 2q33–q34
IGF binding protein 7 (IGFBP7)1 6.56 (3) Regulation of cell growth 4q12
Jagged 1 (JAG1)1 7.04 (4) Notch signaling pathway 20p12
Mesoderm-specific transcript (MEST) 9.21 (1) Mesoderm development 7q32
Nerve growth factor beta (NGFB)1 7.91 (1) Cell–cell signaling, development 1p13
Netrin 4 (NTN4)1 17.10 (1) Basement membrane/extracellular
matrix
12q23
Nuclear receptor subfamily 2 group
F2 (NR2F2)1
2.08 (2) Transcriptional regulation 15q26
Osteomodulin (OMD) 4.34 (2) Cell adhesion 9q22.31
piggyBac transposable element
derived 3 (PGBD)1
4.44 (3) DNA repair 10q11.23
RAB3B1 3.81 (4) Small GTPase-mediated signal
transduction
1p32
Sine oculis 1 (SIX1) 3.97 (1) Transcriptional regulation 14q23
HC, hydrocortisone.
1Statistically significant by parametric as well as nonparametric analysis.
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10-fold in keloid cells (Table 1). Table S3 compares the
expression of multiple genes in the Wnt pathway in cultures
grown with and without HC, using multiple probe sets on the
Affymetrix chip. In addition to the genes listed in Tables 1
and 2, we observed statistically significant differences in
expression of several other Wnt pathway genes in cells grown
in the absence of HC when expression of individual genes
was analyzed using Student’s t-test for unpaired data. These
differences include a more than fivefold reduction in
expression of SFRP2 (Po0.03), a 1.7-fold increase in FZD2
expression (Po0.04), and a 1.8-fold increase in FZD7
expression (Po0.02) in keloid versus normal cells in standard
culture medium. When cultures were grown with HC,
differential expression of SFRP1 and SFRP2, as well as
increases in FZD2, FZD4, and FZD7 were also observed,
although the difference for SFRP1 was less pronounced.
Decreased expression of DKK1 and DKK3 by keloid
fibroblasts was not observed in the presence of HC. The
differential regulation of DKK1, DKK3, and SFRP1 by HC
further extends the subset of fibrosis-related genes that are
glucocorticoid resistant in keloid cells.
Expression of some IL-1-responsive genes is decreased in keloid
fibroblasts
As seen in Tables 2 and 4, expression of several genes
regulated by IL-1 was significantly reduced in keloid
fibroblasts. Table S3 presents expression values for these
genes, some of which were lowered more than twofold, but
statistical significance was not attained due to interstrain
variation. In addition to a 20-fold decreased expression of
chemokine (CXC type) ligand (CXCL)-1 and a greater than
twofold reduction in CXCL-12 seen in Table 2, a 99-fold
reduction in CXCL-6 was observed in the absence of HC. In
addition to the more than 20-fold reduction in expression of
Table 4. Subset of genes with decreased expression in keloid fibroblasts in the presence of HC
Gene name (Gene symbol)
Keloid/normal
(number probe sets) Biological function
Chromosomal
location
Angiopoietin 1 (ANGPT) 0.28 (2) Angiogenesis, signal transduction,
development
8q22–q23
Chemokine (CXC) ligand 1 (CXCL1)1 0.11 (1) Chemotaxis, inflammatory response,
cell proliferation
4q21
Chemokine (CXC) ligand 12
(CXCL12)
0.12 (1) Inflammatory response, immune
response, cell adhesion, cell–cell
signaling
10q11.1
Collagen type XVIII alpha
1(COL18A1)
0.38 (2) Cell adhesion, cell proliferation,
organ morphogenesis
21q22.3
Cyclin-dependent kinase inhibitor 3
(CDKN3)1
0.27 (2) Negative regulation of cell
proliferation
14q22
Dermatopontin (DPT) 0.10 (3) Cell adhesion 1q12–q23
Dickkopf homolog 2 (DKK2) 0.12 (1) Negative regulation of Wnt signaling
pathway
4q25
Discs large homolog 7 (DLG7)1 0.23 (1) Cell–cell signaling, cell proliferation 14q22.2
Interleukin-1 receptor, type 1 (ILR1)1 0.30 (1) Signal transducer activity 2q12
Interleukin-7 (IL7)1 0.06 (1) Immune response, cell–cell signaling 8q12–q13
Matrix metalloproteinase 3 (MMP3)1 0.02 (1) Collagen catabolism 11q22.3
Matrix metalloproteinase 7 (MMP7)1 0.02 (1) Collagen catabolism 11q21–q22
Membrane metallo-endopeptidase
(MME)1
0.12 (2) Proteolysis and peptidolysis 3q25.1–q25.2
Pleiotrophin (heparin binding growth
factor) (PTN)
0.26 (1) Regulation of cell cycle 7q33–q34
Stathmin-like 2 (STMN2)1 0.02 (2) Intracellular signaling 8q21.11–q21.12
Thyroid hormone receptor, beta
(THRB)1
0.05 (2) Transcriptional regulation 3p24.1
Tissue factor pathway inhibitor 2
(TFPI2)1
0.09 (2) Blood coagulation, endopeptidase
inhibitor
7q21.3
Transforming growth factor-b
receptor II (TGFBR2)
0.55 (1) Cell proliferation, extracellular
matrix production
3p22
Transforming growth factor-b
receptor III (TGFBR3)
0.45 (1) Cell proliferation, extracellular
matrix production
1p33–p32
1Statistically significant by parametric as well as nonparametric analysis.
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matrix metalloproteinase (MMP)-3 (Table 2), MMP-1 expres-
sion was reduced fourfold (P¼0.06). Reduced expression of
these genes in keloid cells was also observed in the presence
of HC.
Validation of microarray findings using quantitative real-time
PCR
To validate differences in expression of a selected subset of
genes from Tables 1-4 and Table S3, RNA from the
microarray studies was analyzed by quantitative real-time
(QRT)-PCR.
As seen in Table 6 using comparisons of unpooled normal
strains 21, 58, 116, and 170 and keloid strains 50, 124, 145,
and 261 in control medium, and normal strains 21, 116, and
170 and keloid strains 50, 124, 145, and 261 grown with HC,
PCR findings validated those seen in microarray, and
differences in expression were quantitatively similar. The
more than twofold difference in expression of several genes
that did not reach significance in the microarray studies,
including SFRP2, MMP-1, and IL-13Ra2, were also validated
by QRT-PCR. As also seen in Table 6, using the same strains,
QRT-PCR corroborated findings that the increased expression
of elastin, IGFBP-3, and CTGF in keloid cells only in the
presence of HC could be accounted for by a reduced
sensitivity to HC downregulation. The effect of HC on all
genes listed in Table 6 is seen in Table S4. We had reported
previously differential regulation of several collagen genes by
HC (Russell et al., 1989), but in the microarray studies HC
failed to downregulate collagen mRNA in either cell type. To
mimic previous conditions, we grew additional cultures of
normal strains 21, 58, 116, 131, and 170 and keloid strains
33, 50, 124, 145, and 261 in media supplemented with
50mM ascorbic acid. RNA samples from these strains were
used to perform QRT-PCR on the COL1A1, elastin, CTGF,
IGFBP-3, IGFBP-2, and IGFBP-5 genes. In the presence of
ascorbic acid, the COL1A1 gene, as well as the elastin, CTGF
and IGFBP-3 genes, were expressed at higher levels in keloid
than in normal cells when grown with HC compared to
cultures grown without added hormone (Table S5). As in the
absence of ascorbate, this was attributable to a reduced
sensitivity of keloid cells to HC downregulation (Table S5).
Downregulation of collagen by HC in normal cells appears to
require the presence of ascorbate. As in the absence of
ascorbate, IGFBP-2 expression was increased by HC and
IGFBP-5 was decreased to a similar extent in normal and
keloid cells, emphasizing that differential regulation by HC is
confined to a subset of fibrosis-related genes.
DISCUSSION
Microarray studies provide a broad spectrum of differentially
regulated genes that may play roles in the pathogenesis of
disease. However, it is not feasible to carry out independent
measurements of RNA levels and functional studies for all
abnormally expressed genes; therefore, we focused on the
most likely candidates involved in fibrosis and keloid
formation for validation and future study.
Our observation of increased expression in keloid cells of
several IGFBPs, including IGFBP-3 and -5, and the IGFBP-
related proteins IGFBP-7 and CTGF, is of particular interest.
Roles for IGFBP-3 and -5 in fibrosis are supported by their
increased expression in dermal fibroblasts from patients with
systemic sclerosis (Feghali and Wright, 1999; Knauer et al.
(2001)), idiopathic pulmonary fibrosis (Pilewski et al., 2005;
Yasuoka et al., 2006b), and leiomyomas (Tsibris et al., 2002),
and by their stimulation of matrix synthesis in lung fibroblasts
(Pilewski et al., 2005). Increased CTGF expression has been
observed in several fibrotic conditions (Ihn, 2002), including
keloids (Igarashi et al., 1996). Moreover, increased expres-
sion of IGFBP-3 has been reported in other studies of keloids
(Tosa et al., 2005; Satish et al., 2006). Activation of the IGF-1
receptor has been associated with abnormal cell proliferation
and differentiation in various diseases and with increased
invasive activity of fibroblasts in keloids (Yoshimoto et al.,
1999; Phan et al., 2003). In addition to binding to IGF-1,
IGFBP-3 and -5 bind to extracellular matrix components,
have nuclear localization signals, and bind to putative
receptors on the cell surface (Mohan and Baylink, 2002).
Recently, it was reported that injection of C57BL/6J mice with
adenovirus expressing human IGFBP-5-induced skin fibrosis
(Yasuoka et al., 2006a). We observed increased expression of
IGFBP-3 and CTGF in keloid cells only in the presence of HC.
HC alters transcription of many genes, upregulating some
and downregulating others (Diamond et al., 1990). Its effects
vary with cell type and stage of development (Russell et al.,
1978, 1988). Glucocorticoids generally impair wound heal-
ing (Meisler et al., 1997) and inhibit collagen expression
in normal fibroblasts (references cited in Russell et al.,
1989). When used with TGF-b, glucocorticoids prevent
stimulation of synthesis of collagen and tissue inhibitors of
Table 5. Expression of genes in several HOX gene
clusters in keloid versus normal fibroblasts
Gene symbol
Keloid/normal
control
Keloid/normal
HC
Chromosome
location
HOXA3 0.21 0.28 7p14–p15
HOXA5 0.19 0.08 7p14–p15
HOXA9 0.03 0.02 7p14–p15
HOXA10 0.09 0.08 7p14–p15
HOXA11 0.09 0.10 7p14–p15
HOXB2 0.51 0.58 17q21.3
HOXB5 0.42 0.50 17q21.3
HOXB6 0.09 0.15 17q21.3
HOXB7 0.22 0.31 17q21.3
HOXC6 0.23 0.16 12q13.3
HOXC9 0.05 0.07 12q13.3
HOXC10 0.02 0.01 12q13.3
HOXD4 0.42 0.49 2q31.1
HOX, homeotic.
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metalloproteinases, and reduce scarring (Slavin et al., 1994;
Meisler et al., 1997; Song et al., 1999). They are considered
to be opposing physiological regulators of wound healing and
fibrosis. Although most genes are up- or down-regulated by
HC to a similar extent in normal and keloid cells, the HC-
refractory expression of a subset of TGF-b-inducible genes in
keloid fibroblasts, including several collagen genes, elastin,
IGFBP-3, and CTGF, suggests a role for glucocorticoid
resistance in the pathogenesis of keloids. Antagonism
between glucocorticoids and TGF-b in wound healing points
toward an abnormality in their interaction that may confer
susceptibility to fibrosis.
The highly conserved Wnt family of signaling proteins
participates in multiple developmental events (Habas and
Dawid, 2005; Moon, 2005) and in normal wound healing
(Labus et al., 1998; Okuse et al., 2005). Overexpression of
Table 6. QRT-PCR validation of differences in gene expression seen in microarray
Gene expression in keloid relative to normal fibroblasts in control versus hydrocortisone-supplemented medium
Gene symbol
Normal/normal (range)
control n=4
Keloid/normal (range)
control n=4, n=4
Normal/normal (range)
HC, n=3
Keloid/normal (range)
HC, n=4, n=3
CDKN3 1.00 (0.55–1.82) 0.44 (0.22–0.90) 1.00 (0.71–1.42) 0.98 (0.38–2.50)
COL1A1 1.00 (0.75–1.32) 1.46 (1.01–2.09) 1.00 (0.78–1.28) 1.16 (0.73–1.85)
CTGF 1.00 (0.66–1.51) 1.37 (0.65–2.88) 1.00 (0.71–1.41) 6.28 (3.40–11.60)
DKK1 1.00 (0.80–1.25) 0.35 (0.16–0.76) 1.00 (0.87–1.14) 0.67 (0.28–1.57)
DKK3 1.00 (0.61–1.64) 0.17 (0.08–0.39) 1.00 (0.62–1.61) 0.46 (0.20–1.05)
DLG7 1.00 (0.49–2.03) 0.41 (0.22–0.76) 1.00 (0.63–1.59) 0.31 (0.15–0.63)
DPT 1.00 (0.60–1.67) 0.04 (0.01–0.36) 1.00 (0.59–1.70) 0.02 (0.00–0.14)
ELN 1.00 (0.52–1.93) 0.66 (0.38–1.16) 1.00 (0.66–1.52) 3.04 (1.19–7.75)
F2R 1.00 (0.20–5.11) 13.88 (7.45–25.90) 1.00 (0.24–4.11) 9.63 (1.10–84.08)
FZD4 1.00 (0.57–1.74) 3.06 (1.92–4.87) 1.00 (0.14–7.22) 1.48 (0.63–3.52)
IGFBP2 1.00 (0.39–2.59) 56.1 (10.85–290.15) 1.00 (0.77–1.29) 6.36 (1.73–23.46)
IGFBP3 1.00 (0.36–2.81) 0.57 (0.18–1.81) 1.00 (0.36–2.81) 3.88 (1.31–11.45)
IGFBP5 1.00 (0.36–2.77) 9.63 (2.98–31.12) 1.00 (0.54–1.85) 7.50 (0.89–63.38)
IGFBP7 1.00 (0.53–1.88) 6.66 (3.84–11.56) 1.00 (0.57–1.74) 5.77 (2.61–12,76)
IL13RA1 1.00 (0.91–1.10) 0.89 (0.65–1.22) 1.00 (0.38–2.61) 2.19 (1.10–4.35)
IL13RA2 1.00 (0.57–1.75) 0.02 (0.01–0.04) 1.00 (0.35–2.88) Not detectable in keloid
IL8 1.00 (0.26–3.91) 0.02 (0.01–0.06) 1.00 (0.52–1.91) 0.28 (0.04–1.93)
JAG1 1.00 (0.52–1.91) 9.70 (4.50–20.89) 1.00 (0.55–1.80) 8.09 (3.37–19.42)
MEST 1.00 (0.64–1.56) 51.63 (19.20–138.83) 1.00 (0.40–2.47) 25.83 (6.40–104.15)
MMP1 1.00 (0.35–2.88) 0.17 (0.02–1.36) 1.00 (0.30–3.38) 0.19 (0.04–0.88))
MMP3 1.00 (0.24–4.13) 0.01 (0.001–0.07) 1.00 (0.54–1.87) 0.02 (0.01–0.05)
SFRP1 1.00 (0.16–6.34) 0.04 (0.03–0.04) 1.00 (0.15–6.56) 0.17 (0.08–0.37)
SFRP2 1.00 (0.34–2.97) 0.11 (0.02–0.58) 1.00 (0.32–3.11) 0.06 (0.01–0.27)
TGFBR1 1.00 (0.79–1.27) 1.76 (0.92–3.35) 1.00 (0.37–2.71) 1.40 (1.01–1.93)
TGFBR2 1.00 (0.55–1.83) 0.53 (0.30–0.95) 1.00 (0.50–1.99) 0.73 (0.33–1.60)
TGFBR3 1.00 (0.72–1.39) 3.60 (1.49–8.84) 1.00 (0.46–2.19) 0.19 (0.36–2.13)
Effect of HC on CTGF, elastin, and IGFBP-3 gene expression in normal versus keloid fibroblasts
Gene symbol Normal control/normal
control (range) n=4
Normal HC/normal control
(range) n=3
Keloid control/keloid
control (range) n=4
Keloid HC/keloid control
(range) n=4
CTGF 1.00 (0.61–1.64) 0.22 (0.15–0.31) 1.00 (0.48–2.10) 1.03 (0.56–1.90)
ELN 1.00 (0.45–2.23) 0.28 (0.19–0.43) 1.00 (0.57–1.76) 1.30 (0.45–3.74)
IGFBP3 1.00 (0.85–1.18) 0.11 (0.04–0.32) 1.00 (0.31–3.20) 0.65 (0.22–1.91)
HC, hydrocortisone; QRT-PCR, quantitative real-time PCR.
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Wnt signaling molecules has been observed in pulmonary
fibrosis (Morrisey, 2003), renal fibrosis (Surendran et al.,
2002), leiomyoma (Mangioni et al., 2005), and, most
recently, keloids (Sato, 2006). Our observation of reduced
expression of several inhibitors of Wnt signaling in keloid
fibroblasts indicates a role for this pathway in the pathogen-
esis of keloids. Of particular note is the dramatic reduction of
SFRP1 expression in keloid fibroblasts. Epigenetic silencing of
multiple SFRPs, including SFRP1 and SFRP2, often occurs in
early stages of the neoplastic process (Suzuki et al., 2004;
Baylin and Ohm, 2006), and has been seen in a variety of
malignancies (Caldwell et al., 2006). Epigenetic silencing of
DKK1 has also been observed in colorectal cancer (Aguilera
et al., 2006). Although overexpression of the canonical
pathway in keloids was reported (Sato, 2006), increased
expression of DAAM1 (Table 1), a mediator in the RhoA-
activated noncanonical Wnt signaling pathway, suggests
involvement of that pathway as well. Involvement of this
pathway in fibrosis is supported by evidence that activation of
pancreatic stellate cells is blocked by Rho kinase inhibitors
(Masamune et al., 2003). Furthermore, the DAAM1 gene is
located at chromosomal region 14q22–q23, a region linked to
keloid formation (Davis et al., 2000). Increased Wnt signaling
is consistent with our observation of a 10-fold increase in
expression of JAG1 in keloid fibroblasts. JAG1, a ligand in the
Notch signaling pathway, is a target of Wnt (Katoh and Katoh,
2006). However, increased JAG1 expression may also reflect
an elevated TGF-b response. Functional interactions between
TGF-b/Smad and Notch signaling in various tissues have been
suggested, based on hierarchical activation of one pathway
by the other, or by coordinate regulation of common target
genes (Zavadil and Bottinger, 2005). A third possibility is that
increased JAG1 expression is due to the combined effects of
TGF-b and Wnt (Labbe et al., 2007).
A statistically significant twofold reduction in expression
of TGF-b receptor II (TGFbR2) combined with a small (1.4-
fold) increase in expression of TGFbR1, was observed in
keloid fibroblasts. This fits with the observation of an
increased ratio of TGFbR1/TGFbR2 in keloid cells compared
with hypertrophic scar and normal skin fibroblasts (Bock
et al., 2005), and with reports that an increased ratio of
TGFbR1/TGFbR2 may promote fibrosis (McCaffrey, 2000;
Bock et al., 2005).
In an earlier study to test the hypothesis that altered
production or response to Th2 cytokines plays a role in the
pathogenesis of keloids, RNase protection was used to
determine mRNA levels for IL-13, IL-4, and their receptors
(Smith, 2005). These Th2 cytokine mRNAs were not expressed
at detectable levels in normal or keloid fibroblasts, and IL-4Ra
and IL-13Ra1 mRNAs were expressed at similar levels in both
cell types. However, expression of the decoy receptor IL-
13Ra2 (Chiaramonte et al., 2003), which was low in normal
cells, was virtually absent in keloid cells. These results were
validated in our microarray studies, although the more than
20-fold reduction in average expression was not statistically
significant because of low and variable expression in normal
fibroblasts. These findings and their validation by QRT-PCR
support a role for increased IL-13 activity in keloid formation.
Reduced mRNA levels for the IL-1 receptor and for
multiple CXCLs (CXC type) induced by IL-1 support the view
that an alteration in the inflammatory response plays a role in
keloid formation (McCauley et al., 1992; Niessen et al., 1999;
Nirodi et al., 2000). The reduction in expression of the IL-1-
regulated genes MMP-1 and MMP-3 may account, at least in
part, for the abnormal turnover of matrix components.
Increased levels of collagenase inhibitors in keloid tissue
and reduced degradation of collagen polypeptides in keloid
cell cultures has been observed (Niessen et al., 1999). IL-13
increased collagen synthesis in cultured normal and keloid
fibroblasts and inhibited the production of IL-1b-induced
MMP-1 and MMP-3 (Oriente et al., 2000). These findings are
in agreement with our observation of reduced expression of
IL-1-inducible genes and of the decoy receptor IL-13Ra2.
Reduced expression of multiple HOX genes, highly
conserved master control genes (Chopra and Mishra, 2006),
may also contribute to the altered epigenetic program of
keloids. Although HOX genes play major roles in anterior-
posterior development in the embryo, some regulate gene
expression in adult differentiated cells, including human
dermal fibroblasts (Chang et al., 2002). Silencing of specific
HOXA and HOXD genes has been observed in human lung
adenocarcinomas and in some normal lung tissue of cancer
patients (Shiraishi et al., 2002). Differential expression of
HOX genes may be a component of the tumorigenic
phenotype of keloids. Alternatively, it may be related to
different anatomic sites from which cultures were isolated
(Chang et al., 2002). As seen in Table S6, normal and keloid
cultures used in this study were not site-matched because
tissues were excised only for medical reasons due to the high
risk of keloid formation even in African Americans with no
history of keloid formation. The possibility that anatomic
location may account for differential gene expression is
contraindicated by earlier reports that differential regulation
of several genes and cell growth by HC is confined to cells
from the keloid lesion. Cultures from the superficial dermis of
the same keloids act like cultures from normal scars and skin
(Russell et al., 1978, 1989, 1995). Also, as seen in Figure 1,
keloid strain 145 from a patient’s back clustered with strains
from earlobes, all of the normal strains clustered together,
and the complete data set (available at GSE7890 at
geo@ncbi.nlm.nih.gov) shows that for most genes whose
expression differed between normal and keloid cultures,
including all HOX genes except B6, B7, and C6, expression
in cell strain 145 was similar to that of other keloid strains.
Studies on fibroblasts from additional keloids and normal
scars and from perilesional and lesional cultures from the
same keloids should further clarify this issue.
Some differentially regulated genes in keloid fibroblasts,
including IGFBP-3 and dermatopontin, were misexpressed in
other gene profiling studies (Catherino et al., 2004; Tosa
et al., 2005; Satish et al., 2006), whereas the reported
overexpression of IL-6-related genes in keloid fibroblasts
(Tosa et al., 2005; Ghazizadeh et al., 2007) was not seen
here. These and other differences in gene expression reported
from different laboratories may be due to differences in origin
of cultures, culture conditions, or the microarray platform.
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Relevant to the potential of microarray analysis to identify
candidate genes and susceptibility loci for keloid formation is
our observation that several misregulated genes are located at
14q22–q23, a region linked to keloid formation (Davis et al.,
2000). Potential relevance is evident for some of these
misexpressed genes. SIX1 is overexpressed in multiple tumors
and abrogates growth control (OMIM 601205); DAAM1 is a
mediator of a noncanonical Wnt signaling pathway (OMIM
606626); DLG7 is a mammalian homolog of a family of
Drosophila tumor suppressors (OMIM 601014); and cyclin-
dependent kinase inhibitor-3 is a growth inhibitor (OMIM
123832). Other misregulated genes, including IGFBP-2,
IGFBP-5, FZD7, HOXD, STAT-1, IGFBP-3, and HOXA, are
located on chromosomal arms 2q or 7p, reported to be linked
to keloid formation (Marneros et al., 2004).
In conclusion, these studies support involvement of genes
in a limited number of fibrosis-associated pathways, includ-
ing the IGF-1, Wnt, IL-1, and IL-13 signaling pathways,
provide preliminary evidence for epigenetic silencing of a
subset of genes in the altered program of keloid fibroblasts,
further support a role for glucocorticoid resistance in the
pathogenesis of keloids, and suggest candidate genes for
keloid formation. Reports that some differentially regulated
genes in these pathways are also differentially expressed in
scleroderma and leiomyoma, that decreased dermatopontin
expression has been reported in keloid tissue (Catherino
et al., 2004), leiomyoma (Tsibris et al., 2002; Catherino et al.,
2004), systemic sclerosis, and hypertrophic scars (Kuroda
et al., 1999), and that increased expression of mesoderm-
specific transcript has also been observed in leiomyoma
(Tsibris et al., 2002) support the view that common patterns
of misregulation are present in these fibrotic disorders that
occur with disproportionately high frequency in individuals
of African origin, and suggest common susceptibilities and
therapeutic strategies.
MATERIALS AND METHODS
Cell culture
Methods of isolation and propagation of fibroblasts from keloids and
normal scars have been described (Russell et al., 1978). Briefly,
cultures were initiated by mincing tissue and immobilizing the
pieces under a glass coverslip. Fibroblasts that migrate from the
pieces were subcultured twice and aliquots were frozen in liquid
nitrogen, using a programmable freezer (Planer Products, Sudbury
on Thames, UK). Sources of cell strains, all of which were obtained
from African-American patients, are described in earlier publications
(Russell et al., 1978, 1989; Trupin et al., 1983; Meyer et al., 2000).
Sources of strains used in this study are provided in Table S6. The
medical ethical committees of Vanderbilt University, Tennessee
Valley Health Care System, and Meharry Medical College have
approved all described studies. The study was conducted according
to the Declaration of Helsinki Principles.
Cultures were grown at 371C in an atmosphere of air and CO2
adjusted to maintain a pH of 7.4 with 100% relative humidity. The
standard culture medium consisted of 90% F-10 (Sigma, St Louis,
MO) and 10% fetal bovine serum (Invitrogen, Grand Island, NY). No
antibiotics or antimycotics were used. Cells were subcultured using
0.025% trypsin (Invitrogen) and 0.004% NaEDTA.
Microarray
Strains at low passage number were thawed from liquid nitrogen
storage, subcultured in 60-mm culture dishes and grown to
confluency (10 days) under standard culture conditions with daily
feeding with or without 1.5 mM HC (Sigma). Experimental cultures
were plated at 5 103 cells per cm2, using a Coulter Counter to
determine the appropriate dilution of cell suspensions. Total RNA
was isolated from pooled triplicate cultures using a standard TRIzol
(Invitrogen) method with DNase treatment followed by a second
TRIzol extraction. Pooling three cultures of each strain helps ensure
that variation between strains is due to a biological difference rather
than a technical artifact introduced during culture or subsequent
manipulation.
After verifying the high quality of the RNA, biotinylated
complementary RNA (15mg) was prepared for Affymetrix microarray
analysis in the Vanderbilt Microarray Shared Resource. Biotinylated
complementary RNA (15 mg) was fragmented and hybridized to an
Affymetrix GeneChip (U133 Plus 2.0 Array) containing sets of 11
different 25-mer oligonucleotides, each representing one of 47,000
human transcripts and variants from 38,500 human genes. Hybri-
dized complementary RNA was detected using streptavidin coupled
with phycoerythrin and visualized using a laser scanner. Image data
were quantitated to generate gene expression values and ratios of
gene expression between various combinations of samples. Each
RNA sample was analyzed on a single GeneChip. The resulting data
set was appropriate for statistical analysis of differences between
strains of the same type as well as for comparisons of gene
expression patterns between keloid and normal strains.
Analysis of microarrays
Following data collection, arrays were analyzed using both the
MAS5.0 algorithm (default Affymetrix approach; Affymetrix Users
Guide, www.affymetrix.com) and the Robust Multichip Analysis
approach (Bolstad et al., 2003). The MAS5.0 algorithm is the most
widely used analysis method for GeneChips. The Robust Multichip
Analysis algorithm, an alternative analysis procedure that is more
robust than MAS5.0 (Bolstad et al., 2003) for data with normal errors
or long-tailed symmetric errors (robust fitting) (Cleveland, 1981), was
used in the statistical analyses.
Following normalization, average gene expression values for
normal strains were used as the baseline comparison for all arrays.
Using the average baseline, genes that were differentially expressed
in keloid strains were identified using parametric and nonparametric
(Wilcoxon rank sum test) techniques with corrections for multi-
testing, in this case the Benjamini–Hochberg method. Version 7.2 of
Genespring was used for statistical analyses. This version uses an F
distribution to calculate the P-value after the nonparametric t-test.
Following data analysis, all microarray data sets were annotated
based on MIAME standards (www.mged.org), and were made
publicly available according to those standards using the series
record number GSE7890 at geo@ncbi.nlm.nih.gov.
QRT-PCR
Additional aliquots of RNA prepared for microarray were used to
validate microarray findings by QRT-PCR. RNA was reverse-
transcribed using a cDNA Archive kit (Applied Biosystems, Foster
City, CA). Assays were performed in the Molecular Genetics Core
Laboratory of the Skin Diseases Research Center at Vanderbilt
www.jidonline.org 1307
JC Smith et al.
Gene Expression Profiling in Keloid Fibroblasts
University Medical Center, using an iQ real-time PCR system
(Bio-Rad Laboratories, Hercules, CA). Measurements of specific
gene expression were obtained using predesigned gene-specific
fluorescently labeled 50 nuclease probe-based assays (Applied
Biosystems), as per manufacturer’s protocols. Each predesigned
assay is tested and standardized for reproducible expression analysis
by the manufacturer. Primers, probes, and complementary DNA
(50 ng equivalents) were added to iQ supermix (Bio-Rad Labora-
tories) in a final volume of 20 ml. Each reaction was run in triplicate
for the gene of interest and a housekeeping gene, 18 s ribosomal
RNA. Each assay was validated using 10-fold serial dilutions of
human complementary DNA to examine its specific dynamic
range. Because of the high abundance of 18 s ribosomal RNA,
complementary DNA samples were diluted 1/100 to permit
examination within the dynamic range of the 18 s rRNA 50 nuclease
assay. Universal thermal cycling parameters were used (3min
activation at 951C, followed by 40 cycles of 15 seconds at 951C
and 1minute at 601C).
Fold differences in expression of selected genes between normal
and keloid strains were estimated using the comparative CT method
described in User Bulletin No. 2 ABI PRISM 7700 Sequence
Detection System (Applied Biosystems 2001). The ranges for fold
differences were determined by evaluating the expression 2DDCT
7s, where s is the SD of DDCT.
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